A practical reference on IGF-1 marker: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2025-08-07. Anything still debated is marked as such rather than presented as settled.
Pharmacodynamic studies show that tesamorelin reduces visceral adipose tissue more than subcutaneous adipose tissue in the studied population. This selectivity may relate to differences in blood flow and hormone sensitivity between fat depots. Effects on glucose metabolism and insulin sensitivity have been investigated, with some trials reporting modest changes and others showing stability. The precise relationship between growth hormone exposure, IGF-1 levels, and visceral fat loss remains an active area of analysis.
Tesamorelin binds to growth hormone-releasing hormone receptors on somatotroph cells in the anterior pituitary. Receptor activation increases intracellular cyclic AMP and promotes synthesis and secretion of growth hormone. Because the peptide mimics endogenous GHRH, it amplifies the normal pulsatile release of growth hormone rather than providing exogenous growth hormone directly. This upstream action distinguishes tesamorelin from recombinant growth hormone preparations and from growth hormone secretagogues that act at different receptors.
Stimulated growth hormone release leads to hepatic production of insulin-like growth factor 1, a key mediator of many growth hormone effects. In clinical studies, tesamorelin increased IGF-1 levels in a dose-dependent manner, although the response varies among individuals. The drug's effect on visceral fat is thought to involve growth hormone-mediated lipolysis and altered adipocyte metabolism. Muscle mass and lean body mass have also been assessed as secondary outcomes, but changes are generally smaller and less consistent than fat reductions.
Measured responses usually involve growth hormone and insulin-like growth factor 1, known as IGF-1. Growth hormone rises in bursts and is difficult to sample reliably, while IGF-1 shifts more slowly and can be assessed from a single blood draw. Studies therefore treat IGF-1 as the more practical pharmacodynamic marker. Both are indirect, showing that the receptor was engaged rather than that the peptide reached a particular concentration. Direct exposure measurement requires an assay aimed at the molecule itself.
Published work tends to frame tesamorelin as a tool for studying the GHRH axis and as a compound with measurable effects on body composition. Reports often describe visceral adipose tissue as an endpoint, assessed by imaging rather than by inference. Analytical sections commonly describe liquid chromatography with tandem mass spectrometry to confirm identity and purity, because immunoassays may cross-react with related fragments. Where results diverge between studies, differences in assay choice, sampling timing, and population are frequent explanations offered. Whether effects persist after treatment stops remains an open question.
Tesamorelin binds the growth hormone–releasing hormone receptor on pituitary somatotroph cells. The receptor signals through the Gs protein, raising intracellular cAMP and activating protein kinase A. That cascade triggers release of stored growth hormone in pulses rather than a steady stream. Because the drug acts at the receptor that normally controls this process, its effect depends on the body's own signaling architecture rather than on a synthetic pathway. The resulting hormone profile reflects the timing of each pulse, not only its size.
| Property | Value | Notes |
|---|---|---|
| Primary target | Growth hormone-releasing hormone receptor | Located on anterior pituitary somatotroph cells. |
| Receptor class | G protein-coupled receptor | Activation increases intracellular cyclic AMP. |
| Main downstream hormone | Growth hormone and insulin-like growth factor 1 | Growth hormone release precedes IGF-1 elevation. |
| Primary studied effect | Reduction in visceral adipose tissue | Measured by computed tomography in clinical trials. |
| Approximate half-life | 26–38 minutes after subcutaneous administration | Values vary by assay and study population. |
Tesamorelin acts on the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in intracellular cyclic AMP, which in turn opens ion channels and raises calcium concentrations, leading to release of stored growth hormone into the bloodstream. Because the peptide works through the same receptor as the body's own GHRH, the resulting secretion follows a pulsatile pattern rather than a continuous elevation. The N-terminal modification slows enzymatic breakdown, so the signal persists longer than it would with the unmodified hormone.
Growth hormone released from the pituitary stimulates the liver and other tissues to produce insulin-like growth factor 1, a stable circulating protein that serves as a practical marker of activity. Clinical studies therefore track IGF-1 concentrations alongside the hormone itself, and they commonly measure body composition with imaging rather than relying on body weight alone. Visceral adipose tissue, the fat surrounding abdominal organs, is quantified by computed tomography in the studies that supported approval. Adverse effects reported in trials include injection-site reactions, joint pain, and increases in blood glucose, which is why monitoring accompanies use.
Insulin-like growth factor 1 is produced largely in the liver in response to growth hormone signaling. Its concentration shifts over days rather than minutes, which makes it practical for tracking changes across a study period. Interpretation still depends on age, nutritional status, and concurrent illness, all of which independently affect the marker. Reference ranges are therefore stratified, and comparisons are usually made within an individual over time rather than against a single population threshold.
Assays for these markers differ in calibration and antibody specificity, so results from different platforms are not always interchangeable. Reported values can shift when a laboratory changes method, even without any biological change. Studies that span long periods or multiple sites often need cross-validation of assays. This methodological variability is a recognized limitation when comparing findings across published reports, and it remains a topic of ongoing standardization work.
Measuring the effect of a growth hormone-releasing hormone analogue requires markers that reflect pituitary output rather than the peptide itself. The two most frequently used are growth hormone and insulin-like growth factor 1. Growth hormone fluctuates sharply across the day and responds to sleep, stress, and meals, so isolated readings can be difficult to interpret. Insulin-like growth factor 1 changes more slowly and is often treated as the more stable integrated marker of axis activity.
Research supply is often accompanied by a certificate of analysis listing chromatographic purity, mass confirmation, and storage conditions. Laboratories compare that document with an independent test when material is intended for bench work, since certificates describe a batch rather than an individual vial. Published studies usually state the source and purity of the peptide because small differences in purity can shift measured activity. Full analytical validation is rarely reported, which leaves batch-to-batch comparability an open question.
The peptide is supplied as a lyophilized powder in single-use vials and is normally kept refrigerated between two and eight degrees Celsius, protected from light. Once dissolved, the solution is handled carefully because peptide bonds and the acyl modification can degrade under warm or alkaline conditions. Vials are inspected for cracks, and the powder is checked for color and uniformity before handling. Temperature excursions during shipping are a frequent reason for quality questions.
Identity and purity are assessed with reversed-phase high-performance liquid chromatography, which separates the peptide from truncated or oxidized forms. Mass spectrometry confirms the expected molecular weight, and peptide mapping after enzymatic digestion verifies the amino acid sequence. Water content is measured because residual moisture affects stability, and tests for aggregates or particulates are standard for injectable peptides. Circular dichroism can indicate whether the molecule has adopted an unexpected secondary structure in solution.
质量控制项目一般包括外观、身份、纯度、含量、有关物质、水分和微生物限度。身份确认可通过肽图谱、氨基酸分析和质谱完成，纯度则用面积归一化法计算。研究级材料与药品级材料的要求不同，前者常缺少完整药典验证。不同批次间杂质谱是否影响活性，仍是一个需要具体数据回答的问题。
特沙莫瑞林的检测通常依赖反相高效液相色谱和质谱联用。反相色谱可分离肽主峰与缺失序列、氧化产物等杂质，质谱则提供精确质量以确认身份。对于复杂基质中的定量，常采用液相色谱-串联质谱，并配合固相萃取或蛋白沉淀。生物样品中的肽易降解，因此采集和处理条件会影响结果。
=== Towards separation === After Slovenia and Croatia declared independence from the Socialist Federal Republic of Yugoslavia in 1991, Bosnia and Herzegovina declared its sovereignty in October 1991 and organized a referendum on independence in March 1992. The decision of the Parliament of the Socialist Republic of Bosnia and Herzegovina on holding the referendum was taken after the majority of Bosnian Serb members had left the assembly in protest. These Bosnian Serb assembly members invited the Bosnian Serb population to boycott the referendum held on 29 February and 1 March 1992. The turnout in the referendum was 64-67% and the vote was 98% in favor of independence. Independence was declared on 5 March 1992 by the parliament. The referendum and the murder of two Bosnian Serb members of a wedding procession in Sarajevo the day prior to the referendum was utilized by the Bosnian Serb political leadership as a reason to start road blockades in protest. Further political and social deterioration followed, leading to the Bosnian War. The Socialist Republic of Bosnia and Herzegovina was renamed the Republic of Bosnia and Herzegovina on 8 April 1992, losing the adjective "Socialist". It began moving toward a fully capitalist economic system. The republic retained socialist realist symbols pending the end of the Yugoslav Wars. The republic was led by Alija Izetbegović in a fractious political environment. In 1992, the Republic declared independence from the Socialist Federal Republic of Yugoslavia.
== Further reading == McCormick, Catherine A. (1981). "Central Projects of the lateral line and eight nerves in the bowfin,Amia Calva" (PDF). The Journal of Comparative Neurology. 197 (1): 1–15. doi:10.1002/cne.901970102. hdl:2027.42/50011. PMID 6164698. S2CID 8836961. Conlon, J.M.; Youson, J.H.; Whittaker, J. (1991). "Structure and receptor-binding activity of insulin from a holostean fish, the bowfin:Amia Calva". Biochem. J. 276 (Pt 1): 261–264. doi:10.1042/bj2760261. PMC 1151174. PMID 2039477. Nguyen, T. M.; Mommsen, T. P.; Mims, S. M.; Conlon, J. M. (1994). "Characterization of insulins and proglucagon-derived peptides from a phylogenetically ancient fish, the paddlefish: Polyodon spathula". Biochem. J. 300 (2): 339–345. doi:10.1042/bj3000339. PMC 1138167. PMID 8002937. Conlon, J. M.; Youson, J. H.; Mommsen, T. P. (1993). "Structure and biological activity of glucagon and glucagon-like peptide from a primitive bony fish, the bowfin: Amia calva.". Biochem. J. 295 (3): 857–861. doi:10.1042/bj2950857. PMC 1134640. PMID 8240302. Sepkoski, Jack (2002). "A compendium of fossil marine animal genera". Bulletins of American Paleontology. 364: 560. Archived from the original on 2009-02-20. Retrieved 2011-05-17.
Human MHC class I and II are also called human leukocyte antigen (HLA). To clarify the usage, some of the biomedical literature uses HLA to refer specifically to the HLA protein molecules and reserves MHC for the region of the genome that encodes for this molecule, but this is not a consistent convention. The most studied HLA genes are the nine classical MHC genes: HLA-A, HLA-B, HLA-C, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQB1, HLA-DRA, and HLA-DRB1. In humans, the MHC gene cluster is divided into three regions: classes I, II, and III. The A, B and C genes belong to MHC class I, whereas the six D genes belong to class II. MHC alleles are expressed in codominant fashion. This means the alleles (variants) inherited from both parents are expressed equally:
Portugal's culture has developed due to the influence from various civilisations that have crossed Europe, especially the Mediterranean. Later, during the period of Portugal's engagement in the Age of Discovery, cultural elements from outside of Europe were introduced and became a central element of Portuguese national identity. Portugal is known for its heritage and architecture, sacred sites, festivities, poetry, its music (especially the fado), and cuisine (including its wine). As of 2026, UNESCO inscribed 17 properties in Portugal on the World Heritage List. Portugal's national day is on 10 June, celebrated as the Dia de Portugal, de Camões e das Comunidades Portuguesas (Portugal, Camões, and Portuguese Communities Day).
Sources: en.wikipedia.org
=== Economic === As a result of the fighting, Swiss International Air Lines and Lufthansa suspended flights to Beirut, while Lebanon's flag carrier Middle East Airlines relocated five of its 24 aircraft to Istanbul as a precaution. Australia, Canada, France, Germany, Spain and the United Kingdom advised against travelling to Lebanon, whilst the British embassy withdrew family members of its staff.
The charged aerosol detector (CAD) is a detector used in conjunction with high-performance liquid chromatography (HPLC) and ultra high-performance liquid chromatography (UHPLC) to measure the amount of chemicals in a sample by creating charged aerosol particles which are detected using an electrometer. It is commonly used for the analysis of compounds that cannot be detected using traditional UV/Vis approaches due to their lack of a chromophore. The CAD can measure all non-volatile and many semi-volatile analytes including, but not limited to, antibiotics, excipients, ions, lipids, natural products, biofuels, sugars and surfactants. The CAD, like other aerosol detectors (e.g., evaporative light scattering detectors (ELSD) and condensation nucleation light scattering detectors (CNLSD)), falls under the category of destructive general-purpose detectors (see Chromatography detectors).
== Cast == Ruby Lin as Gu Manzhen (顧曼楨) Patrick Tam as Shen Shijun (沈世鈞) Jiang Qinqin as Gu Manlu (顧曼璐) Li Li-chun as Zhu Hongcai (祝鴻才) Hu Ke as Shi Cuizhi (石翠芝) Chang Chang as Xu Shuhui (許叔惠) Xing Minshan as Zhang Yujin (張豫瑾)
Sources: en.wikipedia.org
==== Mesenchymal stromal cells (MSCs) ==== Scientists reported 2012 that MSCs when transfused immediately within few hours post thawing may show reduced function or show decreased efficacy in treating diseases as compared to those MSCs which are in log phase of cell growth (fresh), so cryopreserved MSCs should be brought back into log phase of cell growth in in vitro culture before administration. Re-culturing of MSCs will help in recovering from the shock the cells get during freezing and thawing. Various MSC clinical trials which used cryopreserved product immediately post thaw have failed as compared to those clinical trials which used fresh MSCs.
=== Militant memoirs and propaganda === The Turner Diaries (1978) is a work of fiction, but is confirmed to have inspired terrorist attacks and far-right extremist movements. In the final scene before the epilogue, the main character carries out a suicide attack on The Pentagon, in an aircraft carrying a nuclear bomb.
== Further reading == Lottermoser, A. (1908). "Uber das Ausfrieren von Hydrosolen". Chemische Berichte. 41 (3): 532–540. doi:10.1002/cber.19080410398. J. Laurie, Freeze Casting: a Modified Sol-Gel Process, University of Bath, UK, Ph.D. Thesis, 1995 M. Statham, Economic Manufacture of Freeze-Cast Ceramic Substrate Shapes for the Spray-Forming Process, Univ. Bath, UK, Ph.D. Thesis, 1998 S. Deville, "Freezing Colloids: Observations, Principles, Control, and Use." Springer, 2017 Wegst, Ulrike G. K.; Kamm, Paul H.; Yin, Kaiyang; García-Moreno, Francisco (25 April 2024). "Freeze casting". Nature Reviews Methods Primers. 4 (1) 28. doi:10.1038/s43586-024-00307-5.
==== Hypoglycemic glucagon impairment ==== Glucagon secretion is normally increased upon falling glucose levels, but normal glucagon response to hypoglycemia is blunted in type 1 diabetics. Beta cell glucose sensing and subsequent suppression of administered insulin secretion is absent, leading to islet hyperinsulinemia which inhibits glucagon release. Autonomic inputs to alpha cells are far more important for glucagon stimulation in the moderate to severe ranges of hypoglycemia, yet the autonomic response is blunted in several ways. Recurrent hypoglycemia leads to metabolic adjustments in the glucose-sensing areas of the brain, shifting the threshold for counterregulatory activation of the sympathetic nervous system to lower glucose concentration. This is known as hypoglycemic unawareness. Subsequent hypoglycemia is met with impairment in the sending of counter-regulatory signals to the islets and adrenal cortex. This accounts for the lack of glucagon stimulation and epinephrine release that would normally stimulate and enhance glucose release and production from the liver, rescuing the diabetic from severe hypoglycemia, coma, and death. Numerous hypotheses have been produced in the search for a cellular mechanism of hypoglycemic unawareness. A consensus has yet to be reached. The major hypotheses are summarized in the following table:
Sources: en.wikipedia.org
It targets the growth hormone-releasing hormone receptor on pituitary somatotroph cells. Binding stimulates cyclic AMP signaling and growth hormone secretion. This is the same receptor used by endogenous GHRH.
It does not act directly on adipose tissue as a primary mechanism. Instead, it increases endogenous growth hormone, which then influences lipolysis and fat distribution. The reduction in visceral fat is an indirect pharmacodynamic effect.
Tesamorelin acts upstream at the pituitary to amplify natural pulsatile growth hormone release. Growth hormone injections provide exogenous hormone and bypass pituitary regulation. The two approaches therefore differ in feedback control and hormonal dynamics.
It acts on the growth hormone–releasing hormone receptor, a Gs-coupled receptor found on pituitary somatotroph cells. Activation raises cAMP and prompts pulsatile hormone release.